Subscribe to the InfoTech eNewsletter

infoTECH News

TMCNet:  Transgene Announces Upcoming Investor Meetings and R&D Day

[April 10, 2017]

Transgene Announces Upcoming Investor Meetings and R&D Day

Regulatory News:

Transgene (Paris:TNG) today announced that management will participate in the upcoming investor events set out below.

  • Kempen 10th Life Sciences Conference: April 19, 2017 - Amsterdam, Netherlands
  • Kepler Biotech Days: June 9, 2017 - Paris, France

Transgene will host a "R&D Day", on June 22, 2017 in Paris, France. The event which will be conducted in English will feature presentations from several leading international scientists and clinicians.

Next scheduled financial communication

1st quarter 2017 business update
April 25, 2017 after market close

About Transgene
Transgene S.A. (Euronext: TNG), part of Institut M�riux, is a publicly traded French biopharmaceutical company focused on designing and developing targeted immunotherapies for the treatment of cancer and infectious diseases. Transgene's programs utilize viral vector technology with the goal of indirectly or directly killing infected or cancerous cells. The Company's�two lead clinical-stage programs are: TG4010, a therapeutic vaccine for non-small cell lung cancer and Pexa-Vec, an oncolytic virus for liver cancer. The Company has several other programs in clinical and preclinical development. Transgene is based in Strasbourg, France, and has additional operations in Lyon, as well as a joint venture in China. Additional information about Transgene is available at

Follow us on Twitter (News - Alert): @TransgeneSA

[ InfoTech Spotlight's Homepage ]

blog comments powered by Disqus


Subscribe to InfoTECH Spotlight eNews

InfoTECH Spotlight eNews delivers the latest news impacting technology in the IT industry each week. Sign up to receive FREE breaking news today!
FREE eNewsletter

infoTECH Whitepapers